Single and Multiple Dose Safety, Tolerability and Pharmacokinetics of the Selective M1 Receptor Partial Agonist HTL0018318 in Healthy Volunteers

被引：0

作者：

Nathan, Pradeep ^{[1
]}

Liptrot, Jan ^{[1
]}

Bakker, Charlotte ^{[1
]}

'tHart, Ellen ^{[1
]}

Klaassen, Erica ^{[1
]}

Prins, Samantha ^{[1
]}

van der Doef, Thalia ^{[1
]}

Walker, Mike ^{[1
]}

Brown, Giles ^{[1
]}

Brown, Alastair ^{[1
]}

Congreve, Miles ^{[1
]}

Weir, Malcolm ^{[1
]}

Marshall, Fiona ^{[1
]}

Cross, David ^{[1
]}

Groeneveld, Geert Jan ^{[1
]}

Tasker, Tim ^{[1
]}

机构：

[1] Sosei Heptares, Cambridge, England

来源：

NEUROPSYCHOPHARMACOLOGY | 2018年 / 43卷

关键词：

M1 and M4 Muscarinic Receptors; Phase; 1; Safety; Pharmacokinetics; Dementia;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

W51

引用

页码：S408 / S409

页数：2

共 50 条

[31] Single and multiple dose pharmacokinetics and tolerability of HX-1171, a novel antioxidant, in healthy volunteers
Kim, Yo Han
Choi, Hee Youn
Lee, Shi Hyang
Lim, Hyeong-Seok
Miki, Tokutaro
Kang, Jong-Koo
Han, Kyoung-Goo
Bae, Kyun-Seop
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 1735 - 1742
[32] Tolerability, safety, and pharmacokinetics of single and multiple oral dosages of R115866 in healthy volunteers
Cools, Marina
Cauwenbergh, Geert
Vanhoutte, Frederic
Vandeplassche, Lieve
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB194 - AB194
[33] Pharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers
Tenero, David
Farinola, Nicholas
Berkowitz, Elchonon M.
Tiffany, Courtney A.
Qian, Yanwen
Xue, Zhengyu
Raychaudhuri, Aparna
Gardiner, David F.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (06): : 754 - 764
[34] UCB 34714: Single and multiple rising dose safety, tolerability, and pharmacokinetics in healthy subjects
Rolan, P
Pigeolet, E
Stockis, A
EPILEPSIA, 2004, 45 : 314 - 315
[35] PHARMACOKINETICS AND TOLERABILITY OF THE ORAL SELECTIVE PROSTACYCLIN RECEPTOR AGONIST SELEXIPAG AFTER MULTIPLE-DOSE ADMINISTRATION IN HEALTHY MALE SUBJECTS
Kaufmann, P.
Okubo, K.
Sidharta, P.
Mant, T.
Dingemanse, J.
Mukai, H.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S88 - S89
[36] Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers
Chung, David T.
Tsai, Cheng-Yuan
Chen, Shu-Jen
Chang, Li-Wen
King, Chi-Hsin R.
Hsu, Ching-Hung
Chiu, Kit-Mui
Tan, Hao-Chen
Chang, Yu-Ting
Hsu, Ming-Chu
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 411 - 417
[37] SINGLE AND MULTIPLE DOSE PHARMACOKINETICS AND SAFETY OF VIXOTRIGINE IN HEALTHY JAPANESE AND CAUCASIAN VOLUNTEERS.
Naik, H.
Versavel, M.
Dunbar, J.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S64 - S64
[38] Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers
Maria Rosario
Timothy Wyant
Timothy Leach
Serap Sankoh
Catherine Scholz
Asit Parikh
Irving Fox
Brian G. Feagan
Clinical Drug Investigation, 2016, 36 : 913 - 923
[39] Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers
Rosario, Maria
Wyant, Timothy
Leach, Timothy
Sankoh, Serap
Scholz, Catherine
Parikh, Asit
Fox, Irving
Feagan, Brian G.
CLINICAL DRUG INVESTIGATION, 2016, 36 (11) : 913 - 923
[40] PHARMACOKINETICS AND TOLERABILITY OF ABT-089, A NOVEL NEURONAL NICOTINIC RECEPTOR PARTIAL AGONIST, IN HEALTHY VOLUNTEERS, FOLLOWING MULTIPLE TWICE DAILY DOSES
Garimella, Tushar
Xiong, Hao
Locke, Charles
Awni, Walid
Dutta, Sandeep
JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1067 - 1067

← 1 2 3 4 5 →